Duquesne Family Office’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-85,445	Closed	-$3.09M	–	77
2025 Q1	$3.09M	Hold	85,445	–	–	0.1%	46
2024 Q4	$3.6M	Hold	85,445	–	–	0.1%	70
2024 Q3	$4.75M	Buy	+85,445	New	+$4.75M	0.16%	63